<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02618434</url>
  </required_header>
  <id_info>
    <org_study_id>810P302</org_study_id>
    <nct_id>NCT02618434</nct_id>
  </id_info>
  <brief_title>Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Supernus Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Supernus Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the efficacy, safety and tolerability of SPN-810
      in the treatment of impulsive aggression in patients with Attention Deficit/Hyperactivity
      Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 291 subjects aged
      6 to 12 years with ADHD and comorbid impulsive aggression will be recruited in this study.
      The frequency of impulsive aggression behaviors will be assessed as a primary outcome.
      Additionally, the severity and improvement in impulsive aggression, and quality of life
      measures for the subject and caregiver will be assessed using validated scales.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of impulsive aggression behaviors per 7 days over a period of 7 weeks.</measure>
    <time_frame>7 weeks</time_frame>
    <description>The frequency of impulsive aggression behaviors will be assessed using an impulsive aggression diary, a newly developed and validated electronic observer reported outcome measurement tool.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">291</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder (ADHD)</condition>
  <arm_group>
    <arm_group_label>Low dose SPN-810</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be treated with low dose of SPN-810</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose SPN-810</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be treated with high dose of SPN-810</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will be treated with a Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPN-810</intervention_name>
    <arm_group_label>Low dose SPN-810</arm_group_label>
    <arm_group_label>High dose SPN-810</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Otherwise healthy male or female subjects, age 6 to 12 years at the time of screening
             with a primary diagnosis of ADHD and currently receiving monotherapy treatment with an
             optimized FDA-approved ADHD medication.

          -  Impulsive aggression will be confirmed at screening using R-MOAS and Vitiello
             Aggression Scale.

        Exclusion Criteria:

          -  Current or lifetime diagnosis of epilepsy, major depressive disorder, bipolar
             disorder, schizophrenia or related disorder, personality disorder, Tourette's
             disorder, or psychosis not otherwise specified.

          -  Currently meeting DSM criteria for autism spectrum disorder, pervasive developmental
             disorder, obsessive compulsive disorder, post-traumatic stress disorder, or any other
             anxiety disorder as primary diagnosis.

          -  Known or suspected intelligence quotient (IQ) &lt; 70, suicidality, pregnancy, or
             substance or alcohol abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Schwabe, MD, PhD</last_name>
    <phone>301-838-2527</phone>
    <email>sschwabe@supernus.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Metropolitan Neuro Behavioral Institute</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Woodland International Research Group</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jim Aukstuolis, MD</last_name>
      <phone>501-221-8681</phone>
      <email>drjim@woodlandintlresearchgrp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sun Valley Research Center</name>
      <address>
        <city>Imperial</city>
        <state>California</state>
        <zip>92251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernardo Ng, MD</last_name>
      <phone>760-545-0123</phone>
      <email>bng@sunvalleyb.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alliance for Wellness dba Alliance for Research</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>ASCLEPES Research Center</name>
      <address>
        <city>Panorama City</city>
        <state>California</state>
        <zip>91402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>MCB Clinical Research Centers, LLC</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80910</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Sedillo, MD</last_name>
      <phone>719-634-6576</phone>
      <email>asedillo@mcbcrc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center/Children's Research Institute</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robb Adelaide, MD</last_name>
      <phone>202-476-3042</phone>
      <email>arobb@childrensnational.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gulfcoast Clinical Research Center</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Indago Research &amp; Health Center, Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Perez, MD</last_name>
      <phone>305-825-6588</phone>
      <email>mperez@indagoresearch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Innovative Clinical Research, Inc</name>
      <address>
        <city>Lauderhill</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rishi Kakar, MD</last_name>
      <phone>954-990-6326</phone>
      <email>rkakar@segalinstitute.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laszlo J. Mate, M.D., P.A.</name>
      <address>
        <city>North Palm Beach</city>
        <state>Florida</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>APG Research, LLC</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadjafi Morteza, MD</last_name>
      <phone>407-423-7149</phone>
      <phone_ext>165</phone_ext>
      <email>moriapg@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Americo Padilla, MD</last_name>
      <phone>305-598-3125</phone>
      <email>americo.padilla@qps.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of South Florida- Dept. of Psychiatry and Neurosciences</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Fallon, MD</last_name>
      <phone>813-974-2832</phone>
      <email>dfallon1@health.usf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atlanta Center for Medical Research</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Riesenberg, MD</last_name>
      <phone>404-881-5800</phone>
      <email>rriesenberg@acmr.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>iResearch Atlanta</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimball Johnson, MD</last_name>
      <phone>404-537-1281</phone>
      <email>drjohnson@iresearchatlanta.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research</name>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <zip>83642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Turner, MD</last_name>
      <phone>208-377-8653</phone>
      <email>mark.turner@acr-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AMR Conventions Research</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandeep Gaonkar, MD</last_name>
      <phone>630-983-2000</phone>
      <email>drgaonkar@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pedia Research</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47715</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Pedia Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carroll Howard, MD</last_name>
      <phone>270-685-4589</phone>
      <email>carroll@pediaresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Louisiana State University Health Sciences Center</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Horton, MD</last_name>
      <phone>318-813-2070</phone>
      <email>ShvPsychopharmacology@lsuhsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Saunders, CCRC</last_name>
      <phone>318-813-2085</phone>
      <email>SSaun1@lsuhsc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Charles Psychiatric Associates Midwest Research Center</name>
      <address>
        <city>Saint Charles</city>
        <state>Missouri</state>
        <zip>63304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg Mattingly, MD</last_name>
      <phone>636-946-8032</phone>
      <email>drmattingly@midwestresearchgroup.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alivation Research, LLC</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Quality Clinical Research</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Hassmann Research Institute</name>
      <address>
        <city>Berlin</city>
        <state>New Jersey</state>
        <zip>08009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Hassman, DO</last_name>
      <phone>856-756-7335</phone>
      <phone_ext>666</phone_ext>
      <email>hhassman@hritrials.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Department of Psychiatry and Behavioral Neuroscience</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caleb Adler, MD</last_name>
      <phone>513-558-2989</phone>
      <email>caleb.adler@uc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BioBehavioral Research of Austin P.C.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Divyansu Patel, MD</last_name>
      <phone>512-382-6661</phone>
      <email>dpatel@clin-edge.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>InSite Clinical Research</name>
      <address>
        <city>DeSoto</city>
        <state>Texas</state>
        <zip>75115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajinder Shiwach, MD</last_name>
      <phone>972-283-6286</phone>
      <email>rshiwach@aol.com</email>
    </contact>
    <contact_backup>
      <last_name>, MDPA</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Houston Clinical Trials</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Katic, MD</last_name>
      <phone>713-527-8839</phone>
      <email>akatic@houstonclinitrials.com</email>
    </contact>
    <contact_backup>
      <last_name>M</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ericksen Research &amp; Development</name>
      <address>
        <city>Clinton</city>
        <state>Utah</state>
        <zip>84015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Bostrom, MD</last_name>
      <phone>801-614-5501</phone>
      <email>medicalway@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pacific Institute of Medical Sciences</name>
      <address>
        <city>Bothell</city>
        <state>Washington</state>
        <zip>98011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2015</study_first_submitted>
  <study_first_submitted_qc>November 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2015</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

